Black Friday

All the Features.
Half the Price.

$149.00 / first year $299.50

Then $299.50/year

Last Close
95.86
Nov 18 • 3:56 PM ET Dollar change-0.46 Percentage change(-0.48%)
Index
RUT
Market Cap
6.50B
Enterprise Value
5.59B
Income
-152.57M
Sales
0.00M
Book/sh
17.78
Cash/sh
13.57
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
68
IPO
Aug 08, 1997
P/E
-
Forward P/E
-
PEG
-
P/S
-
P/B
5.39
P/C
7.06
P/FCF
-
EV/EBITDA
-
EV/Sales
-
Quick Ratio
29.62
Current Ratio
29.62
Debt/Eq
0.00
LT Debt/Eq
0.00
Option/Short
Yes / Yes
EPS (ttm)
-2.47
EPS next Y
-2.95
EPS next Q
-0.75
EPS this Y
-37.83%
EPS next Y
-15.72%
EPS next 5Y
-26.32%
EPS past 3/5Y
34.61% 37.79%
Sales past 3/5Y
- -
EPS Y/Y TTM
-2.35%
Sales Y/Y TTM
-
EPS Q/Q
-1.57%
Sales Q/Q
-
Insider Own
11.21%
Insider Trans
-34.71%
Inst Own
106.13%
Inst Trans
36.26%
ROA
-17.53%
ROE
-18.12%
ROIC
-12.72%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
SMA20
-1.94%
SMA50
6.58%
SMA200
30.26%
Trades
Shs Outstand
67.23M
Shs Float
60.22M
52W High
115.51 -17.02%
52W Low
25.23 279.94%
Volatility
6.24% 6.26%
ATR (14)
5.73
RSI (14)
50.30
Beta
-0.32
Rel Volume
0.39
Avg Volume
952.76K
Volume
370,000
Perf Week
-10.55%
Perf Month
21.20%
Perf Quarter
-8.58%
Perf Half Y
58.00%
Perf YTD
216.27%
Perf Year
249.22%
Perf 3Y
720.61%
Perf 5Y
548.61%
Perf 10Y
-64.89%
Prev Close
96.32
Price
95.86
Change %
-0.48%
Consensus
Strong Buy
Avg. Price Target
$152.23
Implied Upside
+58.8%
Analysts12incl. previous ratings
Rating Distribution12 Buy · 0 Hold · 0 Sell
DateActionAnalystRating ChangePrice Target ChangeImplied Upside
Dec 18, 2025Initiated
PPiper Sandler
Overweight$75-21.8%
Nov 13, 2025Initiated
JEF logoJJefferies
Buy$45-53.1%
Oct 27, 2025Initiated
GGuggenheim
Buy$60-37.4%
Oct 13, 2025Initiated
BCS logoBBarclays
Overweight$48-49.9%
May 22, 2025Initiated
BBTIG Research
Buy$44-54.1%
Feb 04, 2025Initiated
WWolfe Research
Outperform$20-79.1%
Oct 11, 2024Initiated
SF logoSStifel
Buy$49-48.9%
Oct 07, 2024Initiated
HH.C. Wainwright
Buy$45-53.1%
Sep 17, 2024Initiated
LLeerink Partners
Outperform$44-54.1%
Sep 16, 2024Initiated
TD logoTTD Cowen
Buy
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Goncalves JoanaChief Medical OfficerNov 16 '26Option Exercise7.327,00051,24038,771Nov 16 06:44 PM
Goncalves JoanaChief Medical OfficerNov 16 '26Sale100.967,000706,70031,771Nov 16 06:44 PM
Agarwal ArjunSenior Vice President, FinanceNov 12 '26Option Exercise15.6910,000156,91624,219Nov 13 08:03 PM
Agarwal ArjunSenior Vice President, FinanceNov 12 '26Sale104.9710,0001,049,65814,219Nov 13 08:03 PM
BALL KRISTINE MDirectorNov 12 '26Option Exercise6.8418,000123,12018,000Nov 13 07:59 PM
BALL KRISTINE MDirectorNov 12 '26Sale104.9318,0001,888,7490Nov 13 07:59 PM
Arjun AgarwalOfficerNov 12 '26Proposed Sale107.1729,4583,157,014Nov 12 04:20 PM
KRISTINE BALLDirectorNov 12 '26Proposed Sale107.1718,0001,929,060Nov 12 04:19 PM
Klein Lawrence OttoChief Executive OfficerNov 02 '26Option Exercise7.8025,000195,000948,128Nov 02 05:46 PM
Klein Lawrence OttoChief Executive OfficerNov 02 '26Sale95.6025,0002,390,125923,128Nov 02 05:46 PM
LAWRENCE KLEINDirectorNov 02 '26Proposed Sale96.8725,0002,421,750Nov 02 04:39 PM
Quinlan Paul TGeneral CounselOct 20 '26Option Exercise7.809,00070,20038,995Oct 20 08:42 PM
Quinlan Paul TGeneral CounselOct 20 '26Sale78.539,000706,73529,995Oct 20 08:42 PM
Goncalves JoanaChief Medical OfficerOct 15 '26Option Exercise7.327,00051,24038,771Oct 15 06:15 PM
Goncalves JoanaChief Medical OfficerOct 15 '26Sale74.817,000523,64831,771Oct 15 06:15 PM
JOANA GONCALVESOfficerOct 15 '26Proposed Sale76.6821,0001,610,280Oct 15 04:38 PM
Agarwal ArjunSenior Vice President, FinanceOct 12 '26Option Exercise15.699,999156,90324,218Oct 13 04:34 PM
Agarwal ArjunSenior Vice President, FinanceOct 12 '26Sale80.609,999805,88914,219Oct 13 04:34 PM
Arjun AgarwalOfficerOct 12 '26Proposed Sale82.119,999821,018Oct 13 08:24 AM
Klein Lawrence OttoChief Executive OfficerOct 01 '26Option Exercise7.8025,000195,000948,128Oct 02 07:54 PM
Klein Lawrence OttoChief Executive OfficerOct 01 '26Sale83.6225,0002,090,593923,128Oct 02 07:54 PM
LAWRENCE KLEINDirectorOct 01 '26Proposed Sale83.2925,0002,082,250Oct 01 04:22 PM
Agarwal ArjunSenior Vice President, FinanceSep 21 '26Sale95.7553351,03514,219Sep 21 05:38 PM
Quinlan Paul TGeneral CounselSep 21 '26Option Exercise7.8010,00078,00039,995Sep 21 04:57 PM
Quinlan Paul TGeneral CounselSep 21 '26Sale93.6410,000936,41729,995Sep 21 04:57 PM
Arjun AgarwalOfficerSep 21 '26Proposed Sale94.9653350,614Sep 21 04:27 PM
Goncalves JoanaChief Medical OfficerSep 15 '26Option Exercise7.327,00051,24039,718Sep 15 07:18 PM
Goncalves JoanaChief Medical OfficerSep 15 '26Sale92.387,947734,14531,771Sep 15 07:18 PM
Agarwal ArjunSenior Vice President, FinanceSep 11 '26Option Exercise15.889,459150,17524,771Sep 15 07:17 PM
Agarwal ArjunSenior Vice President, FinanceSep 11 '26Sale92.239,459872,41215,312Sep 15 07:17 PM
Agarwal ArjunSenior Vice President, FinanceSep 15 '26Sale95.7156053,59814,752Sep 15 07:17 PM
Klein Lawrence OttoChief Executive OfficerSep 15 '26Sale95.712,452234,681923,128Sep 15 07:15 PM
Quinlan Paul TGeneral CounselSep 15 '26Sale95.711,03999,44329,995Sep 15 07:14 PM
Sandler Laura LeeChief Operating OfficerSep 15 '26Sale95.7190686,713235,478Sep 15 07:11 PM
Sandler Laura LeeChief Operating OfficerSep 01 '26Option Exercise7.805,00039,000241,384Sep 01 06:36 PM
Sandler Laura LeeChief Operating OfficerSep 01 '26Sale91.825,000459,101236,384Sep 01 06:36 PM
Klein Lawrence OttoChief Executive OfficerSep 01 '26Option Exercise7.8075,000585,0001,000,580Sep 01 06:35 PM
Klein Lawrence OttoChief Executive OfficerSep 01 '26Sale91.8375,0006,887,484925,580Sep 01 06:35 PM
LAURA SANDLEROfficerSep 01 '26Proposed Sale92.625,000463,100Sep 01 04:50 PM
LAWRENCE KLEINDirectorSep 01 '26Proposed Sale92.6275,0006,946,500Sep 01 04:48 PM
Goncalves JoanaChief Medical OfficerAug 17 '26Option Exercise7.327,00051,24039,718Aug 17 06:09 PM
Goncalves JoanaChief Medical OfficerAug 17 '26Sale111.847,000782,88232,718Aug 17 06:09 PM
Quinlan Paul TGeneral CounselAug 14 '26Option Exercise11.6052,000603,00083,034Aug 14 05:52 PM
Quinlan Paul TGeneral CounselAug 14 '26Sale108.4952,0005,641,40931,034Aug 14 05:52 PM
Agarwal ArjunSenior Vice President, FinanceAug 13 '26Option Exercise15.6910,000156,91625,312Aug 14 05:42 PM
Agarwal ArjunSenior Vice President, FinanceAug 13 '26Sale106.6610,0001,066,57215,312Aug 14 05:42 PM
PAUL QUINLANOfficerAug 14 '26Proposed Sale108.1271,0007,676,520Aug 14 04:39 PM
Goncalves JoanaChief Medical OfficerJul 15 '26Option Exercise7.327,00051,24039,718Jul 15 07:36 PM
Goncalves JoanaChief Medical OfficerJul 15 '26Sale86.287,000603,93832,718Jul 15 07:36 PM
JOANA GONCALVESOfficerJul 15 '26Proposed Sale87.4721,0001,836,870Jul 15 04:31 PM
Agarwal ArjunSenior Vice President, FinanceJul 13 '26Option Exercise15.699,999156,90325,311Jul 13 05:09 PM
Agarwal ArjunSenior Vice President, FinanceJul 13 '26Sale84.639,999846,18015,312Jul 13 05:09 PM
Arjun AgarwalOfficerJul 13 '26Proposed Sale86.7928,5882,481,153Jul 13 04:36 PM
Fairmount Healthcare Fund II LDirector, 10% StockholderJul 01 '26Proposed Sale84.433,553,410300,014,406Jul 01 09:31 PM
Fairmount Funds Management LLCDirectorJul 01 '26Sale84.433,553,410300,014,4061,131,954Jul 01 09:30 PM
Sandler Laura LeeChief Operating OfficerJul 01 '26Option Exercise7.805,00039,000241,384Jul 01 07:58 PM
Sandler Laura LeeChief Operating OfficerJul 01 '26Sale94.425,000472,079236,384Jul 01 07:58 PM
Agarwal ArjunSenior Vice President, FinanceJun 22 '26Sale80.951,587128,46815,312Jun 22 07:59 PM
Agarwal ArjunSenior Vice President, FinanceJun 12 '26Option Exercise15.889,459150,17526,753Jun 15 06:57 PM
Agarwal ArjunSenior Vice President, FinanceJun 12 '26Sale69.729,459659,50817,294Jun 15 06:57 PM
Agarwal ArjunSenior Vice President, FinanceJun 15 '26Sale69.6939527,52816,899Jun 15 06:57 PM
Goncalves JoanaChief Medical OfficerJun 15 '26Option Exercise7.327,00051,24040,665Jun 15 06:54 PM
Goncalves JoanaChief Medical OfficerJun 15 '26Sale69.287,947550,60732,718Jun 15 06:54 PM
Klein Lawrence OttoChief Executive OfficerJun 15 '26Sale69.691,729120,494925,580Jun 15 06:52 PM
Sandler Laura LeeChief Operating OfficerJun 15 '26Sale69.6960041,814236,384Jun 15 06:51 PM
Quinlan Paul TGeneral CounselJun 15 '26Sale69.6973351,08331,034Jun 15 06:50 PM
Dambkowski CarlDirectorJun 11 '26Sale70.1322,4171,572,20151,326Jun 12 04:36 PM
Dambkowski CarlDirectorJun 12 '26Sale70.1112,583882,18238,743Jun 12 04:36 PM
CARL DAMBKOWSKIDirectorJun 11 '26Proposed Sale64.0335,0002,241,050Jun 11 04:24 PM
Dambkowski CarlDirectorMay 21 '26Option Exercise7.9562,260494,805178,743May 22 04:54 PM
Dambkowski CarlDirectorMay 21 '26Sale58.97105,0006,191,36673,743May 22 04:54 PM
CARL DAMBKOWSKIDirectorMay 21 '26Proposed Sale60.67105,0006,370,350May 21 04:32 PM
Agarwal ArjunSenior Vice President, FinanceMay 18 '26Option Exercise28.807,833225,59726,696May 18 06:07 PM
Agarwal ArjunSenior Vice President, FinanceMay 18 '26Sale59.0710,290607,80616,406May 18 06:07 PM
ARJUN AGARWALOfficerMay 18 '26Proposed Sale61.9322,2061,375,218May 18 04:34 PM
Goncalves JoanaChief Medical OfficerMay 15 '26Option Exercise7.327,00051,24040,377May 15 08:17 PM
Goncalves JoanaChief Medical OfficerMay 15 '26Sale61.857,000432,93533,377May 15 08:17 PM
Sandler Laura LeeChief Operating OfficerMay 01 '26Option Exercise7.805,00039,000241,984May 01 06:25 PM
Sandler Laura LeeChief Operating OfficerMay 01 '26Sale63.885,000319,384236,984May 01 06:25 PM
LAURA SANDLEROfficerMay 01 '26Proposed Sale68.4110,000684,100May 01 04:42 PM
Goncalves JoanaChief Medical OfficerApr 15 '26Option Exercise7.327,00051,24040,377Apr 15 06:45 PM
Goncalves JoanaChief Medical OfficerApr 15 '26Sale66.127,000462,83033,377Apr 15 06:45 PM
JOANA GONCALVESOfficerApr 15 '26Proposed Sale67.0621,0001,408,260Apr 15 04:54 PM
Klein Lawrence OttoChief Executive OfficerMar 16 '26Sale41.301,72971,408927,309Mar 17 04:10 PM
Agarwal ArjunSenior Vice President, FinanceMar 16 '26Sale41.3039516,31318,863Mar 17 04:09 PM
Sandler Laura LeeChief Operating OfficerMar 16 '26Sale41.3060024,780236,984Mar 17 04:08 PM
Goncalves JoanaChief Medical OfficerMar 16 '26Option Exercise7.327,00051,24041,018Mar 17 04:06 PM
Goncalves JoanaChief Medical OfficerMar 16 '26Sale40.917,641312,56033,377Mar 17 04:06 PM
Quinlan Paul TGeneral CounselMar 16 '26Sale41.3073330,27331,767Mar 17 04:04 PM
Sandler Laura LeeChief Operating OfficerMar 02 '26Option Exercise7.805,00039,000242,584Mar 02 06:47 PM
Sandler Laura LeeChief Operating OfficerMar 02 '26Sale33.565,000167,822237,584Mar 02 06:47 PM
Goncalves JoanaChief Medical OfficerFeb 17 '26Option Exercise7.327,00051,24041,018Feb 17 05:24 PM
Goncalves JoanaChief Medical OfficerFeb 17 '26Sale32.377,000226,55934,018Feb 17 05:24 PM
Goncalves JoanaChief Medical OfficerJan 15 '26Option Exercise7.327,00051,2408,518Jan 16 05:26 PM
Goncalves JoanaChief Medical OfficerJan 15 '26Sale31.817,000222,7041,518Jan 16 05:26 PM
Sandler Laura LeeChief Operating OfficerJan 02 '26Option Exercise7.805,00039,000218,084Jan 02 08:25 PM
Sandler Laura LeeChief Operating OfficerJan 02 '26Sale28.5213,000370,795205,084Jan 02 08:25 PM
LAURA SANDLEROfficerJan 02 '26Proposed Sale30.3118,000545,580Jan 02 04:31 PM
Goncalves JoanaChief Medical OfficerDec 19 '25Option Exercise7.327,00051,2408,518Dec 19 05:38 PM
Goncalves JoanaChief Medical OfficerDec 19 '25Sale30.617,000214,2931,518Dec 19 05:38 PM
Oruka Therapeutics, Inc. is a biotechnology company, which focuses on developing novel monoclonal antibody therapeutics for PsO and other I&I indications. Its pipeline includes ORKA-001 and ORKA-002. The company is headquartered in Menlo Park, CA.
PresidentDr. Lawrence Otto Klein Ph.D.
General Counsel & SecretaryMr. Paul T. Quinlan
Chief Medical OfficerDr. Joana Goncalves M.D.
Senior VP of Finance & TreasurerMr. Arjun Agarwal CPA
Chief Operating OfficerMs. Laura Sandler